ANETUMAB RAVTANSINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 23:30:49 GMT 2025` Edited by `admin` on `Mon Mar 31 23:30:49 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	M170940PMI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ANETUMAB RAVTANSINE

Official Name

English

BAY 94-9343

Preferred Name

English

BAY-94-9343

Code

English

BAY949343

Code

English

BAY94-9343

Code

English

Anetumab ravtansine [WHO-DD]

Common Name

English

BAY-949343

Code

English

anetumab ravtansine [INN]

Common Name

English

Classification Tree Code System Code

EU-Orphan Drug

EU/3/18/2084

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

NCI_THESAURUS

C1512

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

FDA ORPHAN DRUG

370112

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

NCI_THESAURUS

C129823

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

Code System Code Type Description

FDA UNII

M170940PMI

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

NCI_THESAURUS

C98293

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

CAS

1375258-01-7

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

INN

9788

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

DRUG BANK

DB14809

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

EVMPD

SUB177941

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

SMS_ID

100000163575

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

ChEMBL

CHEMBL2109629

Created by admin on Mon Mar 31 23:30:49 GMT 2025 , Edited by admin on Mon Mar 31 23:30:49 GMT 2025

PRIMARY

From	To
1_22	1_96
1_147	1_203
1_264	1_324
1_370	1_428
2_22	2_96
2_147	2_203
2_264	2_324
2_370	2_428
3_22	3_90
3_139	3_198
4_22	4_90
4_139	4_198
1_223	3_216
2_223	4_216
1_229	2_229
1_232	2_232

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					J27WDC343N

TARGET->CONJUGATED TOXIN

Amount:


					WOB38VS2NI

DM4

TOXIN -> CONJUGATE

Amount:

Related Record Type Details


					M170940PMI

ANETUMAB RAVTANSINE

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO_ACID_SUBSTITUTION		RESIDUE_SPECIFIC	K	Amount:	DM4-SPDB-L-LYSINE	6MDF4WB915

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL